{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T20:33:08Z","timestamp":1792873988628,"version":"4.5.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T00:00:00Z","timestamp":1762646400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012025","name":"New York University Abu Dhabi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018003","name":"Les Amis des Instituts Pasteur \u00e0 Bruxelles","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017936","name":"Arkansas Corn and Grain Sorghum Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017936","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.drudis.2025.104531","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T07:43:36Z","timestamp":1763538216000},"page":"104531","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Targeting viral replication complexes with mRNA-encoded nanobodies: a new frontier for antiviral design"],"prefix":"10.1016","volume":"30","author":[{"given":"Jeremy","family":"Blavier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennaro","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Twizere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piergiorgio","family":"Percipalle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2025.104531_b0005","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1128\/br.35.3.235-241.1971","article-title":"Expression of animal virus genomes","volume":"35","author":"Baltimore","year":"1971","journal-title":"Bacteriol Rev"},{"key":"10.1016\/j.drudis.2025.104531_b0010","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/j.ymthe.2022.02.015","article-title":"A systematic approach to identify host targets and rapidly deliver broad-spectrum antivirals","volume":"30","author":"Olivet","year":"2022","journal-title":"Mol Ther"},{"key":"10.1016\/j.drudis.2025.104531_b0015","doi-asserted-by":"crossref","DOI":"10.1126\/science.abm4805","article-title":"Computed structures of core eukaryotic protein complexes","volume":"374","author":"Humphreys","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.drudis.2025.104531_b0020","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2025.104531_b0025","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s41586-019-1923-7","article-title":"Improved protein structure prediction using potentials from deep learning","volume":"577","author":"Senior","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2025.104531_b0030","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/s41586-021-03828-1","article-title":"Highly accurate protein structure prediction for the human proteome","volume":"596","author":"Tunyasuvunakool","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2025.104531_b0035","doi-asserted-by":"crossref","unstructured":"Zhang, J. et al. Computing the Human Interactome. 2024.10.01.615885 Preprint at https:\/\/doi.org\/10.1101\/2024.10.01.615885 (2024).","DOI":"10.1101\/2024.10.01.615885"},{"key":"10.1016\/j.drudis.2025.104531_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102304","article-title":"Nanobody against SARS-CoV-2 non-structural protein Nsp9 inhibits viral replication in human airway epithelia","volume":"35","author":"Venit","year":"2024","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.drudis.2025.104531_b0045","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/363446a0","article-title":"Naturally occurring antibodies devoid of light chains","volume":"363","author":"Hamers-Casterman","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2025.104531_b0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-0716-2075-5_1","article-title":"Nanobodies: from Serendipitous Discovery of Heavy Chain-only Antibodies in Camelids to a Wide Range of Useful applications","volume":"2446","author":"Ji","year":"2022","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.drudis.2025.104531_b0055","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s10555-005-6193-1","article-title":"Prokaryotic expression of antibodies","volume":"24","author":"Arbabi-Ghahroudi","year":"2005","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.drudis.2025.104531_b0060","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0168-1656(00)00274-1","article-title":"Improved production and function of llama heavy chain antibody fragments by molecular evolution","volume":"80","author":"van der Linden","year":"2000","journal-title":"J Biotechnol"},{"key":"10.1016\/j.drudis.2025.104531_b0065","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s40259-019-00392-z","article-title":"The Therapeutic potential of Nanobodies","volume":"34","author":"Jov\u010devska","year":"2020","journal-title":"BioDrugs"},{"key":"10.1016\/j.drudis.2025.104531_b0070","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/978-1-0716-2075-5_5","article-title":"Isolation of Single-Domain Antibodies to Transmembrane Proteins using Magnetized yeast Cell Targets","volume":"2446","author":"Bacon","year":"2022","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.drudis.2025.104531_b0075","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-1-0716-2075-5_3","article-title":"Llama DNA Immunization and Isolation of Functional Single-Domain Antibody Binders","volume":"2446","author":"Trempe","year":"2022","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.drudis.2025.104531_b0080","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/s41586-021-03676-z","article-title":"Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants","volume":"595","author":"Xu","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2025.104531_b0085","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/d41573-019-00104-w","article-title":"Nanobody approval gives domain antibodies a boost","volume":"18","author":"Morrison","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.drudis.2025.104531_b0090","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1080\/22221751.2020.1768806","article-title":"Development of multi-specific humanized llama antibodies blocking SARS-CoV-2\/ACE2 interaction with high affinity and avidity","volume":"9","author":"Dong","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.drudis.2025.104531_b0095","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/s41594-020-0469-6","article-title":"Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2","volume":"27","author":"Huo","year":"2020","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.drudis.2025.104531_b0100","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/s41422-022-00700-3","article-title":"Hetero-bivalent nanobodies provide broad-spectrum protection against SARS-CoV-2 variants of concern including Omicron","volume":"32","author":"Ma","year":"2022","journal-title":"Cell Res"},{"key":"10.1016\/j.drudis.2025.104531_b0105","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s42003-022-03630-3","article-title":"A panel of nanobodies recognizing conserved hidden clefts of all SARS-CoV-2 spike variants including Omicron","volume":"5","author":"Maeda","year":"2022","journal-title":"Commun Biol"},{"key":"10.1016\/j.drudis.2025.104531_b0110","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.cell.2020.04.031","article-title":"Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies","volume":"181","author":"Wrapp","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2025.104531_b0115","article-title":"Intracellular delivery of therapeutic proteins. New advancements and future directions. Front Bioeng","volume":"11","author":"Porello","year":"2023","journal-title":"Biotechnol"},{"key":"10.1016\/j.drudis.2025.104531_b0120","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.cell.2015.03.028","article-title":"Efficient intracellular delivery of native proteins","volume":"161","author":"D\u2019Astolfo","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2025.104531_b0125","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.3390\/biom10111567","article-title":"Transcriptional Profiling reveals Ribosome Biogenesis, Microtubule Dynamics and Expression of specific lncRNAs to be Part of a Common Response to Cell-Penetrating Peptides","volume":"10","author":"Venit","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.drudis.2025.104531_b0130","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1002\/anie.201708459","article-title":"Nanobodies: Chemical Functionalization strategies and Intracellular applications","volume":"57","author":"Schumacher","year":"2018","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.drudis.2025.104531_b0135","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1021\/acs.biomac.5b01335","article-title":"Intracellular delivery of Charge-Converted Monoclonal Antibodies by Combinatorial Design of Block\/Homo Polyion complex Micelles","volume":"17","author":"Kim","year":"2016","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.drudis.2025.104531_b0140","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s40265-020-01378-w","article-title":"Remdesivir: first Approval","volume":"80","author":"Lamb","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.drudis.2025.104531_b0145","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJMoa2116044","article-title":"Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized patients","volume":"386","author":"Jayk Bernal","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.drudis.2025.104531_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2021.102329","article-title":"Molnupiravir in COVID-19: a systematic review of literature","volume":"15","author":"Singh","year":"2021","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.drudis.2025.104531_b0155","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa2118542","article-title":"Oral Nirmatrelvir for High-Risk, Nonhospitalized adults with Covid-19","volume":"386","author":"Hammond","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.drudis.2025.104531_b0160","doi-asserted-by":"crossref","unstructured":"Trepte, P. et al. AI-guided pipeline for protein-protein interaction drug discovery identifies a SARS-CoV-2 inhibitor. bioRxiv 2023.06.14.544560 doi:10.1101\/2023.06.14.544560.","DOI":"10.1101\/2023.06.14.544560"},{"key":"10.1016\/j.drudis.2025.104531_b0165","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/s41587-022-01475-z","article-title":"A proteome-scale map of the SARS-CoV-2-human contactome","volume":"41","author":"Kim","year":"2023","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.drudis.2025.104531_b0170","doi-asserted-by":"crossref","DOI":"10.1002\/adbi.202101113","article-title":"NMR\u2010Based Analysis of Nanobodies to SARS\u2010CoV\u20102 Nsp9 reveals a possible Antiviral Strategy against COVID\u201019","volume":"5","author":"Esposito","year":"2021","journal-title":"Adv Biol"},{"key":"10.1016\/j.drudis.2025.104531_b0175","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1016\/j.molcel.2023.10.001","article-title":"Structural and functional insights into the enzymatic plasticity of the SARS-CoV-2 NiRAN domain","volume":"83","author":"Small","year":"2023","journal-title":"Mol Cell"},{"key":"10.1016\/j.drudis.2025.104531_b0180","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1016\/j.cell.2023.09.002","article-title":"SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9","volume":"186","author":"Schmidt","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2025.104531_b0185","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.cell.2020.11.016","article-title":"Cryo-EM Structure of an Extended SARS-CoV-2 Replication and Transcription complex reveals an Intermediate State in Cap Synthesis","volume":"184","author":"Yan","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2025.104531_b0190","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1128\/JVI.01505-08","article-title":"Severe Acute respiratory Syndrome Coronavirus nsp9 Dimerization is Essential for Efficient Viral Growth","volume":"83","author":"Miknis","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.drudis.2025.104531_b0195","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.virol.2008.10.032","article-title":"Formation of stable homodimer via the C-terminal \u03b1-helical domain of coronavirus nonstructural protein 9 is critical for its function in viral replication","volume":"383","author":"Chen","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.drudis.2025.104531_b0200","doi-asserted-by":"crossref","first-page":"8822","DOI":"10.1093\/nar\/gkab677","article-title":"NMPylation and de-NMPylation of SARS-CoV-2 nsp9 by the NiRAN domain","volume":"49","author":"Wang","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drudis.2025.104531_b0205","first-page":"1308","article-title":"A Biochemical and Biophysical Analysis of the Interaction of nsp9 with nsp12 from SARS-CoV-2\u2014Implications for Future Drug Discovery efforts. Proteins: Structure Function","volume":"92","author":"Baker","year":"2024","journal-title":"Bioinformatics"},{"key":"10.1016\/j.drudis.2025.104531_b0210","doi-asserted-by":"crossref","first-page":"5636","DOI":"10.1038\/s41467-023-41312-8","article-title":"Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets","volume":"14","author":"Mihali\u010d","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2025.104531_b0215","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/pro.3150","article-title":"Structural basis for dimerization and RNA binding of avian infectious bronchitis virus nsp9","volume":"26","author":"Hu","year":"2017","journal-title":"Protein Sci"},{"key":"10.1016\/j.drudis.2025.104531_b0220","article-title":"Crystal Structure of the SARS-CoV-2 Non-structural Protein 9","volume":"23","author":"Littler","year":"2020","journal-title":"Nsp9 Iscience"},{"key":"10.1016\/j.drudis.2025.104531_b0225","doi-asserted-by":"crossref","first-page":"e00692","DOI":"10.1128\/JVI.00692-18","article-title":"Dimerization of Coronavirus nsp9 with Diverse Modes Enhances its Nucleic Acid Binding Affinity","volume":"92","author":"Zeng","year":"2018","journal-title":"J Virol"},{"key":"10.1016\/j.drudis.2025.104531_b0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0303839","article-title":"Assessing nanobody interaction with SARS-CoV-2 Nsp9","volume":"19","author":"Esposito","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2025.104531_b0235","article-title":"TOLLIP inhibits the replication of PEDV by autophagic degradation of Nsp9","volume":"304","author":"Li","year":"2025","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.drudis.2025.104531_b0240","doi-asserted-by":"crossref","first-page":"10949","DOI":"10.1021\/acs.analchem.2c00751","article-title":"Approaching Protein Aggregation and Structural Dynamics by Equilibrium and Nonequilibrium Paramagnetic Perturbation","volume":"94","author":"Hunashal","year":"2022","journal-title":"Anal Chem"},{"key":"10.1016\/j.drudis.2025.104531_b0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0283194","article-title":"Inside-out: Antibody-binding reveals potential folding hinge-points within the SARS-CoV-2 replication co-factor nsp9","volume":"18","author":"Pan","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2025.104531_b0250","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jmb.2008.07.071","article-title":"Variable Oligomerization Modes in Coronavirus Non-structural Protein 9","volume":"383","author":"Ponnusamy","year":"2008","journal-title":"J Mol Biol"},{"key":"10.1016\/j.drudis.2025.104531_b0255","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s43556-020-00005-0","article-title":"Structural basis for the multimerization of nonstructural protein nsp9 from SARS-CoV-2","volume":"1","author":"Zhang","year":"2020","journal-title":"Mol Biomed"},{"key":"10.1016\/j.drudis.2025.104531_b0260","first-page":"341","article-title":"The nsp9 Replicase Protein of SARS-Coronavirus","volume":"12","author":"Sutton","year":"2004","journal-title":"Structure and Functional Insights Structure"},{"key":"10.1016\/j.drudis.2025.104531_b0265","first-page":"176","article-title":"A distinct ssDNA\/RNA binding interface in the Nsp9 protein from SARS-CoV-2. Proteins: Structure Function","volume":"90","author":"El-Kamand","year":"2022","journal-title":"Bioinformatics"},{"key":"10.1016\/j.drudis.2025.104531_b0270","first-page":"418","article-title":"A structural analysis of the nsp9 protein from the coronavirus MERS CoV reveals a conserved RNA binding interface. Proteins: Structure Function","volume":"92","author":"Mani","year":"2024","journal-title":"Bioinformatics"},{"key":"10.1016\/j.drudis.2025.104531_b0275","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s12104-020-09992-1","article-title":"Backbone chemical shift assignments for the SARS-CoV-2 non-structural protein Nsp9: intermediate (ms \u2013 \u03bcs) dynamics in the C-terminal helix at the dimer interface","volume":"15","author":"Buchko","year":"2021","journal-title":"Biomol NMR Assign"},{"key":"10.1016\/j.drudis.2025.104531_b0280","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s12104-021-10011-0","article-title":"Backbone chemical shift spectral assignments of SARS coronavirus-2 non-structural protein nsp9","volume":"15","author":"Dud\u00e1s","year":"2021","journal-title":"Biomol NMR Assign"},{"key":"10.1016\/j.drudis.2025.104531_b0285","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41467-021-27950-w","article-title":"Mapping inhibitory sites on the RNA polymerase of the 1918 pandemic influenza virus using nanobodies","volume":"13","author":"Keown","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2025.104531_b0290","first-page":"615","article-title":"Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants","volume":"595","author":"Xiang","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2025.104531_b0295","first-page":"1090","article-title":"Rationally designed humanized single-domain antibodies to neutralize SARS-CoV-2 variants of concern","volume":"32","author":"Sun","year":"2022","journal-title":"Cell Res"},{"key":"10.1016\/j.drudis.2025.104531_b0300","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/antib8020038","article-title":"Super-potent bispecific llama VHH antibodies neutralize HIV via a combination of gp41 and gp120 epitopes","volume":"8","author":"Beirnaert","year":"2019","journal-title":"Antibodies"},{"key":"10.1016\/j.drudis.2025.104531_b0305","doi-asserted-by":"crossref","first-page":"6961","DOI":"10.1038\/s41467-024-51414-6","article-title":"Highly potent and broadly neutralizing anti-CD4 trimeric nanobodies inhibit HIV-1 infection by inducing CD4 conformational alteration","volume":"15","author":"Zhu","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2025.104531_b0310","doi-asserted-by":"crossref","first-page":"4196","DOI":"10.1038\/s41467-025-58669-7","article-title":"A potent protective bispecific nanobody targeting herpes simplex virus gD reveals vulnerable epitope for neutralizing","volume":"16","author":"Hu","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2025.104531_b0315","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines \u2013 a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.drudis.2025.104531_b0320","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrd4278","article-title":"mRNA-based therapeutics\u2014developing a new class of drugs","volume":"13","author":"Sahin","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.drudis.2025.104531_b0325","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat Rev Mater"},{"key":"10.1016\/j.drudis.2025.104531_b0330","doi-asserted-by":"crossref","first-page":"8913","DOI":"10.1038\/s41467-025-63965-3","article-title":"Engineering of mRNA vaccine platform with reduced lipids and enhanced efficacy","volume":"16","author":"Ma","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2025.104531_b0335","doi-asserted-by":"crossref","unstructured":"Laber, K.E. et al. Chapter 15 - Biology and Diseases of Swine. in Laboratory Animal Medicine (Second Edition) (eds. Fox, J. G., Anderson, L. C., Loew, F. M. & Quimby, F. W.) 615\u2013673 (Academic Press, Burlington, 2002). doi:10.1016\/B978-012263951-7\/50018-1.","DOI":"10.1016\/B978-012263951-7\/50018-1"},{"key":"10.1016\/j.drudis.2025.104531_b0340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0195-5616(93)50001-3","article-title":"Coronavirus infection in cats","volume":"23","author":"Hoskins","year":"1993","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"10.1016\/j.drudis.2025.104531_b0345","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3201\/eid1203.050839","article-title":"Canine Coronavirus Highly Pathogenic for dogs","volume":"12","author":"Buonavoglia","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.drudis.2025.104531_b0350","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2021.643220","article-title":"Bovine Coronavirus and the Associated Diseases","volume":"8","author":"Vlasova","year":"2021","journal-title":"Front Vet Sci"},{"key":"10.1016\/j.drudis.2025.104531_b0355","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1128\/CMR.00102-15","article-title":"Approved Antiviral Drugs over the past 50 Years","volume":"29","author":"De Clercq","year":"2016","journal-title":"Clin Microbiol Rev"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644625002442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644625002442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T12:14:52Z","timestamp":1780920892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644625002442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":71,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1359644625002442"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2025.104531","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting viral replication complexes with mRNA-encoded nanobodies: a new frontier for antiviral design","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2025.104531","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104531"}}